Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
Ziyuan Zhang,Yaling Hu,Wenyuan Liu,Xiaodong Zhang,Ruihua Wang,Hui Li,Dalin Sun,Jingai Fang
DOI: https://doi.org/10.2147/DMSO.S368867
2022-07-25
Abstract:Ziyuan Zhang, 1, 2 Yaling Hu, 1, 2 Wenyuan Liu, 2 Xiaodong Zhang, 2 Ruihua Wang, 2 Hui Li, 2 Dalin Sun, 1, 2 Jingai Fang 2 1 Shanxi Medical University, Taiyuan, People's Republic of China; 2 Department of Nephrology, First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China Correspondence: Jingai Fang, Department of Nephrology, First Hospital of Shanxi Medical University, 85 Jiefangnan Road, Taiyuan, 030001, People's Republic of China, Email Purpose: To explore the mechanism of Yishen capsule against diabetic nephropathy (DN) based on the analysis of transcriptomics. Material and Methods: SD rats (Male, SPF grade) were randomly divided into four groups, the normal group, the DN group, the Yishen capsule group and the resveratrol group. Urine and renal tissue samples were collected after feeding with physiological saline and above drugs for 8 weeks. 24-hour urine microalbumin protein was detected by ELISA. HE staining and PAS staining were performed on renal tissues. Differential gene expression in renal tissues was analyzed by transcriptome sequencing. The differentially expressed genes were analyzed by GO enrichment and KEGG enrichment, and verified by RT-PCR and immunohistochemistry staining. Results: The level of 24-hour urinary microalbumin in DN group was increased, while Yishen capsule treatment reversed the increasement of urinary microalbumin. Mesangial cell proliferation, matrix accumulation, edema and vacuolar degeneration of renal tubular epithelial cells and glycogen accumulation were observed in DN group. However, pathological phenotypes mentioned above were alleviated after Yisen capsule administration. This result indicates that Yishen capsule reversed pathological phenotypes of DN in rats. The expression of 261 genes were changed in Yishen capsule group compared with DN group. GO enrichment analysis and KEGG pathway analysis showed that these genes were implicated in pathways, including mineral absorption, adipocytokine signaling pathway, fatty acid biosynthesis, thyroid hormone synthesis, renin–angiotensin system, and NOD-like receptor signaling pathway. Based on previous reported study, the expression of key factors in NOD-like receptor signaling pathway was verified. RT-PCR and immunohistochemistry staining showed that the expression of NLRP3, Caspase-1 and IL-1β in renal tissues of DN group were increased (P < 0.05), which were decreased in Yishen capsule group (P < 0.05). Conclusion: Yishen capsule reduced microalbuminuria and alleviated pathological changes in DN rats, which may be achieved by regulating NOD-like receptor signaling pathway. Keywords: Yishen capsule, diabetic nephropathy, transcriptome sequencing, NOD-like receptor signaling pathway Diabetic nephropathy (DN) is one of the most common complications of diabetes, and it is a manifestation of diabetic microangiopathy in the kidneys. Recent investigation shows that DN has become the leading cause of end-stage renal disease (ESRD). 1 The etiology and pathogenesis of DN are complex, and it is the result of multiple factors, such as genetics, environment, oxidative stress, and inflammatory mediators. 2–4 At present, the clinical therapeutic schemes for DN are mostly control of blood pressure, blood glucose, blood lipids and dietary nutrition. Although ACEI/ARB can reduce the proteinuria and delay the development of DN, many patients still progress to ESRD. 5 There is a lack of specific drugs for prevention and treatment of DN effectively. Yishen capsule is a traditional Chinese medicine preparation developed by the research group after long-term clinical practice (preparation number, 97Bing Wei Preparation with Zi f01-2005). It is composed of Astragalus membranaceus, Angelica sinensis, Euryale ferox, Alisma orientalis, Schisandra, Rhodiola and other Chinese medicines. It has functions of nourishing kidney-qi, inducing diuresis to reduce edema, regulating and enhancing the body's immunity. 6,7 The previous research of our group showed that Yishen capsule can reduce 24-hour urinary protein and urine β2 microglobulin of DN patients, which indicates a good clinical effect of Yishen capsule on DN. 7 Further studies have shown that Yishen capsule could reduce urinary protein level and restore the expression of podocalyxin and podocyte foot processes in the kidneys of DN rats injected with STZ. 6 Yishen capsules can delay the progression of DN by activating autophagy and repairing podocyte damage through regulating the SIRT1/NF-κB signaling pathway. 8 Recently, our research group conducted a network pharmacological analysis -Abstract Truncated-